Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
go back to news archives| Abbott announced that it has received approval from the U.S. Food and Drug Administration for its fully automated HTLV-I/HTLV-II blood screening test for use on the ABBOTT PRISM instrument. The test is intended for use by laboratories to screen individual donations of blood and plasma for antibodies to human T -- lymphotropic virus Type I and/or human T -- lymphotropic virus Type II (anti-HTLV-I/HTLV-II). HTLV-I and HTLV-II are closely related but distinct retroviruses associated with several diseases including human T-cell leukemia and neurological disorders, according to the Centers for Disease Control. Screening of the U.S. blood supply for HTLV-I/II began in 1988. Used in more than 30 countries, the PRISM system also includes four hepatitis tests: a core hepatitis B test (PRISM HBcore), introduced in October 2005; two hepatitis B surface antigen tests (PRISM HBsAg and HBsAg Confirmatory), introduced in July 2006; and a hepatitis C test (PRISM HCV), introduced in July 2007. |
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : Abbott Laboratories View Company Information
Posted on January 23, 2008
advertisement
advertisement
advertisement
advertisement
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
USP Chapter <86> and the Move to Recombinant Methods
-
2025 Novogene Sequencing Symposium
-
Explore the Future of Sterility Testing with Rapid Micro Biosystems®
-
Understanding USP <73> to Accelerate Sterility Testing for Short-Life Products
-
British Society For Microbial Technology 40th Anniversary Microbiology Conference
-
How Is VIDAS® KUBE™ Transforming Food Pathogen Detection?
-
Sampling and Microbial Testing of Water and Data Trending
-
European Microbiology Conference and Workshop 2025
-
Future Labs Live 2025
-
2025 Endotoxin Testing Summit
